Prognostic value of DICER and CA9 expression in patients with anal squamous cell carcinoma treated with definitive chemoradiotherapy
European Journal of Cancer · 2026-06 · 241 · 116776
DOI: 10.1016/j.ejca.2026.116776 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-06. Verfasst von Melis Onay und 10 weiteren Autor:innen. Beteiligte Einrichtung: Goethe University Frankfurt, University Hospital, Department of Internal Medicine, Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Ribonuclease III, Chemoradiotherapy, Carcinoma, Squamous Cell, Anus Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hessisches Ministerium für Wissenschaft und Kunst, Fonds der Chemischen Industrie, Bundesministerium für Forschung, Technologie und Raumfahrt.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Goethe University Frankfurt, University Hospital, Department of Internal Medicine, Frankfurt am Main, Germany.
- Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt/Main, Germany; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
- Goethe University Frankfurt, Institute of Biochemistry I, Frankfurt am Main, Germany; Department for Immunity of Inflammation, Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg Univ…
- German Cancer Research Center (DKFZ), Heidelberg, Germany; Charité University Hospital, Department of Radiooncology and Radiotherapy, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site, Berlin, Germany.
- German Cancer Research Center (DKFZ), Heidelberg, Germany; Eberhard Karls University Tübingen, University Hospital Tübingen, Department of Radiation Oncology, Tübingen, Germany; German Cancer Consortium (DKTK), Partner…
- Centre for Integrated Oncology, Aachen Bonn Cologne Duesseldorf, Cologne, Germany; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Förderung
- Hessisches Ministerium für Wissenschaft und Kunst
- Fonds der Chemischen Industrie
- Bundesministerium für Forschung, Technologie und Raumfahrt
Zitieren
APA
Onay, M., de Valk, A. F., Weigert, A., Kalinauskaite, G., Tinhofer, I., Gani, C., Fokas, E., Rödel, C., Martin, D., Piiper, A., & Rödel, F. (2026). Prognostic value of DICER and CA9 expression in patients with anal squamous cell carcinoma treated with definitive chemoradiotherapy. European Journal of Cancer, 241, 116776. https://doi.org/10.1016/j.ejca.2026.116776
Vancouver
Onay M, de Valk AF, Weigert A, Kalinauskaite G, Tinhofer I, Gani C, et al. Prognostic value of DICER and CA9 expression in patients with anal squamous cell carcinoma treated with definitive chemoradiotherapy. European Journal of Cancer. 2026;241:116776. doi:10.1016/j.ejca.2026.116776
BibTeX
@article{Onay2026,
author = {Onay, Melis and de Valk, Adalbert F and Weigert, Andreas and Kalinauskaite, Goda and Tinhofer, Ingeborg and Gani, Cihan and Fokas, Emmanouil and Rödel, Claus and Martin, Daniel and Piiper, Albrecht and Rödel, Franz},
title = {Prognostic value of DICER and CA9 expression in patients with anal squamous cell carcinoma treated with definitive chemoradiotherapy},
journal = {European Journal of Cancer},
year = {2026},
volume = {241},
pages = {116776},
doi = {10.1016/j.ejca.2026.116776}
}
EUVIMED